Department of Internal Medicine III, Salzburg Cancer Research Institute, Paracelsus Medical University Salzburg, Austria, Müllner-Hauptstrasse 48, Salzburg 5020, Austria.
BMC Complement Altern Med. 2014 Mar 30;14:115. doi: 10.1186/1472-6882-14-115.
Complementary and alternative medicine is often used by patients with malignant glioma. Although several interactions of various alternative agents with chemotherapy are known, none has been described for temozolomide so far.
We report the case of severe liver toxicity with jaundice during radiochemotherapy with temozolomide likely due to interaction with a popular Chinese herbal formula after surgery for glioblastoma. After cessation of the herbal formula as well as the chemotherapy liver enzymes slowly normalized. Due to tumor progression the patient was retreated with temozolomide for 5 cycles without toxicity. Because of further progression combination treatment of bevacizumab and irinotecan was started and again no liver toxicity was observed.
We conclude that the observed toxicity with jaundice was probably caused by an interaction of this popular Chinese formula and temozolomide. This is the first report about a relevant interaction of temozolomide and any herbal formula.
恶性脑胶质瘤患者常采用补充替代医学。尽管已知多种替代药物与化疗之间存在多种相互作用,但迄今为止尚未有关于替莫唑胺的报道。
我们报告了一例在替莫唑胺放化疗后发生严重肝毒性和黄疸的病例,这可能是由于在胶质母细胞瘤手术后与一种流行的中草药配方发生相互作用。停止使用中草药配方和化疗后,肝酶逐渐恢复正常。由于肿瘤进展,患者重新接受了 5 个周期的替莫唑胺治疗,未出现毒性。由于进一步进展,开始使用贝伐单抗和伊立替康联合治疗,未观察到肝毒性。
我们推断,这种严重黄疸可能是由于这种流行的中草药配方与替莫唑胺之间的相互作用所致。这是第一个关于替莫唑胺与任何草药配方相互作用的报告。